Upadacitinib Monotherapy Shows Positive Results in Rheumatoid Arthritis Trial
June 6th 2018Upadacitinib is currently being tested in phase 3 trials of rheumatoid arthritis, psoriatic arthritis and Crohn’s disease, and is being investigated to treat ulcerative colitis, ankylosing spondylitis, atopic dermatitis and giant cell arteritis.
Read More
Combination Shows Promise for Treating Advanced Non Small Cell Lung Cancer
June 4th 2018Combining pegilodecakin (AM0010) with nivolumab (Opdivo) or pembrolizumab (Keytruda) induced an overall response rate (ORR) of 41% in patients with advanced non–small cell lung cancer (NSCLC), according to findings from an early phase study presented at the 2018 ASCO Annual meeting.
Read More
Combination Effective Treating Non Small Cell Lung Cancer
June 4th 2018Pegilodecakin (AM0010) with nivolumab (Opdivo) or pembrolizumab (Keytruda) induced an overall response rate in 41% in patients with advanced non–small cell lung cancer, according to findings presented at the 2018 ASCO Annual meeting.
Read More
ASHP Votes to Create Section of Specialty Pharmacy Practitioners
June 4th 2018American Society of Health-System Pharmacists board votes unanimously to create a new section of practitioners that will help members provide optimal patient care and medication therapy management in specialty pharmacy.
Read More